People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Biotech / Pharma, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Appello Pharmaceuticals, Inc. | — | Biotech / Pharma | Series B | $29.0M | $263.7M | 2018 |
| Cobra Stylet L.L.C. | — | Other Health Care | Pre-Seed | $517K | $15.9M | 2012 |
Christopher P. Rand at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher P. Rand on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Laden | 1 | 7 |
| Vaughn Bryson | 1 | 1 |
| Howard P. Furst | 1 | 1 |
| Joseph P. Cook, Jr. | 1 | 1 |
| William P. Slattery | 1 | 1 |
| Jeff P. Conn | 1 | 1 |
| Howie P. Furst | 1 | 1 |
| James E. Geisler | 1 | 1 |
| David Y. Phelps | 1 | 1 |
| Francis P. Duque | 1 | 1 |
| Barry P. Simon | 1 | 1 |
| Richard P. Trontz | 1 | 1 |
| Robert P. Saunders | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.